Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)

In our latest Psychedelic Patent Analysis, we take a deep dive into recent patent-related developments at two companies that are both pursuing 5-MeO-DMT for treatment-resistant depression (TRD): GH Research and Beckley Psytech. This case study raises questions not only about how these two specific companies’ IP might shake out, but also about how other types of exclusivity—such as data and market…

Source

Climate change to boost temperature-related deaths in Europe

A first pan-European assessment reveals that, even if current climate policies succeed in limiting the global temperature rise to 3°C, temperature-driven mortality may increase.

August 22, 2024

Doctors and scientists experienced alarming rates of personal attacks on social media

Dr. Tricia Pendergrast, a recent Feinberg School of Medicine graduate who led the pre-COVID-19 study on harassment, recalled several responses from people who feared for

June 16, 2023

JAMA: Traditional Medicare Is, In Fact, The Failure

What You Should Know: – A new article published in JAMA Internal Medicine reignites the debate about Medicare Advantage and traditional Medicare. – Dr. Sachin

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.